
Trinity Biotech plc
TRIB
TRIB: Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.
moreShow TRIB Financials
Recent trades of TRIB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by TRIB's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Air tool with modularized air pad Jun. 24, 2014
-
Patent Title: Air-operated device for better sleep Jan. 08, 2013
Federal grants, loans, and purchases
Followers on TRIB's company Twitter account
Number of mentions of TRIB in WallStreetBets Daily Discussion
Recent insights relating to TRIB
Recent picks made for TRIB stock on CNBC
ETFs with the largest estimated holdings in TRIB
Flights by private jets registered to TRIB